Who it may be suitable for Adults living with obesity (BMI 30 or above), or overweight (BMI 27 to under 30) with at least one weight related health condition such as high blood pressure, high cholesterol, or sleep apnoea, where a prescriber decides it is clinically appropriate People who want a needle free option and can commit to a consistent morning routine on an empty stomach People already using a GLP 1 injection who would prefer to move to a daily tablet, subject to clinical review Who it is not suitable for People below the licensed BMI thresholds, or anyone seeking weight loss for cosmetic reasons Women who are pregnant, planning pregnancy, or breastfeeding People with certain medical histories, which our prescriber will screen for during your consultation Side effects The most common side effects of semaglutide are gastrointestinal, such as nausea, constipation, diarrhoea, and vomiting
All parents want their children to lead healthy and fulfilling lives
The brands that win will be the ones that understand what food needs to stand for when appetite isn't the starting point and design products and experiences around that
Each pathway contributes something distinct: GLP-1 reduces appetite and slows gastric emptying, GIP enhances insulin secretion and energy partitioning, and glucagon receptor activation increases energy expenditure and fat oxidation
those prioritizing oral administration despite reduced convenience and efficacy
